Medicinal Cannabis

Grow Group Plans IPO In ‘Next 12 Months’ Following German Expansion

GROW Group told BusinessCann back in 2020 that it was raising £6m in capital to fund its expansion across Europe, setting its sights on...

Ananda Developments Makes 3 New Heavyweight Hires As It Continues ‘Best, Not First’ Strategy

ANANDA Developments has announced a number of heavyweight hires including a new COO, Head of Cultivation and Head of Plant Science, sending its stock...

New Pilot Could See Patients On The Isle Of Man Gain Access To Medical Cannabis For The First Time

THE Isle of Man’s 83,000 inhabitants could soon gain access to medical cannabis for the first time as the Department of Health & Social...

MGC Pharma Reports Strongest Ever Sales as Key Drug Approvals Remain in Limbo

MGC Pharmaceutical has reported its strongest ever quarterly sales figures, but a lack of significant progress on its drug trials and regulatory approvals saw...

Work To Start On UK Mainland’s First Commercial Cannabis Cultivation Facility For Over 20 Years

GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over 20 years.  The deal will...

From Flowers To Pharma – How Europe Is Forging Its Own Medicinal Cannabis Identity

As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US. AFTER picking up their script from a...

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis medicine have emerged with news...

LYPHE Group Opens Swiss Division With Germany And Poland To Follow By End Of Year

ONE of the UK’s fastest growing and largest cannabis companies has launched its first European operation with more to follow over the coming months. The...

Work On £12m Medicinal Cannabis Cultivation Facility Held-Up By Covid-19 UK Travel Ban

ANANDA Developments has secured £300,000 to build out the first phase of its medicinal cannabis growing research facility in Lincolnshire. In May last year the...

Children’s Dutch Epilepsy Cannabis Medicines Will Be Made In The UK To Overcome Import Impasse

A PERMANENT solution to the import impasse on children’s epilepsy cannabis medication has emerged with the Dutch manufacturer set to see the medicines made...

The UK Medical Cannabis Industry Can – And Does – Provide Epilepsy Medicines For Children In Post-Brexit Britain

Pierre Van Weperen of Grow Pharma on the post-Brexit issue surrounding the import of epilepsy cannabis medicines into the UK. MAINTAINING existing quality standards was...

NHS Launching Patient Registry To Support Evidence Base For Cannabis Medicines

THE NHS is to launch is first-ever cannabis patient registry in a move which signifies an ambition for the medicines to become more widely-available...

Huge Rise In UK Medical Cannabis Imports As Private Sector Steps-Up To Meet Patient Demand

NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s growing role in fulfilling...

New Access Scheme Aims To Deliver Medical Cannabis To Thousands Of UK Patients

PATIENTS currently frozen out by an under-performing National Health Service are being offered access to cannabis medicine through a new private sector scheme. Around 700...

Not One Medicinal Cannabis Trial Launched By NHS Since Law Change

A LACK of clinical evidence is a key reason the National Health Service offers for the paucity of medicinal cannabis prescriptions in the UK. So, one...

UK Medicinal Cannabis Impasse – ‘Companies Won’t Invest In Clinical Trials; Medics Only Want Clinical Trials’

A WORLD-LEADING cannabis professor says the UK is caught in a depressing Catch-22 with companies unwilling to invest in clinical trials and medics unwilling...

Grow Pharma Signs Partnership Deal With Australia’s Althea – Boosting UK Medical Cannabis Range by 20%

UK MEDICAL cannabis distributor Grow Pharma has boosted its patient product range by 20% after striking a new deal with Althea Group Holdings. Grow Pharma...

Latest news

Poko Innovations, Inc. Receives Validation And Authorization To Sell 44 Items In The UK

POKO Innovations an award-winning UK-based collection of CBD-focused companies that bring innovative, inspiring solutions to the CBD industry through...

Intercure Posts More Record Results But Says It ‘Could Do So Much More’ If It Had More Supply

INTERCURE has released another set of ‘all time record quarterly’ results, seeing both revenues and profits skyrocket year-on-year.  Despite its...

Stenocare Delivers First Product Batch To The Danish Market

STENOCARE delivers the first product batch of their THC Oil to the Danish market. This means that the product is...

Must read

Intercure Posts More Record Results But Says It ‘Could Do So Much More’ If It Had More Supply

INTERCURE has released another set of ‘all time record...

Chill Brands Targets Near £4m Capital Raise To Fund Fresh Strategy & £1.3m Chill.com Domain

CHILL Brands’ shareholders have voted in favour of plans...

You might also likeRELATED
Recommended to you

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...